2015
$94M
from 10 investors over 10 rounds
Bolt Biotherapeutics, Inc. raised $15M on June 7, 2021
Investors: Genmab
Bolt Biotherapeutics, Inc. raised $94M on July 1, 2020
Investors: Vivo Capital, Novo Holdings, Surveyor Capital, Sofinnova Ventures, Russia technology fund, Samsara BioCapital and RA Capital Management, L.P.
Bolt Biotherapeutics, Inc. raised $54M on February 7, 2019
Investors: Nan Fung Life Sciences, Novo Holdings and Vivo Capital